Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Report from Brazil

September 1, 2013

Pharma eyes biologics production in Brazil as the government begins to recognize the potential of these drugs.

Oncobiologics, inVentiv Health Partner for Biosimilars Development

August 6, 2013

Oncobiologics, Inc. and inVentiv Health announced a global strategic partnership around clinical development for all assets in Oncobiologic?s biosimilar pipeline.

Pharma Invests in Gene Therapy Programs

August 1, 2013

Pharmaceutical companies have stepped up gene therapy development in the wake of the approval of Glybera in 2012.

New Gene Patent Rules

August 1, 2013

The US Supreme Court's Myriad decision satisfied both patient groups and patent holders

Report from India

August 1, 2013

Industry players brace themselves to face challenges as India's new drug-pricing policy kicks in full gear.

Fourth-generation Biologics to Drive $120 Billion Market

July 11, 2013

Fourth-generation biologics, with improved delivery and pharmacokinetics, will continue to drive an overall biologics industry that is already worth over $120 billion.

Financing Innovation

April 1, 2013

Early-stage companies are finding alternatives to venture capital.

Benchmarking: Don't Just Run the Numbers, Understand the Process

April 1, 2013

Benchmarking can be a useful tool to improve manufacturing practices.

Aggregation of Monoclonal Antibody Products: Formation and Removal

March 1, 2013

Aggregate formation is influenced by multiple aspects of the bioproduction process but can be mitigated by good process design and control.

ADVERTISEMENT

ADVERTISEMENT

Click here